Next Article in Journal
Bisphenol E Neurotoxicity in Zebrafish Larvae: Effects and Underlying Mechanisms
Previous Article in Journal
Haustorium Formation and Specialized Metabolites Biosynthesis Using Co-Culture of Castilleja tenuiflora Benth. and Baccharis conferta Kunth
Previous Article in Special Issue
Effect of Probiotics in Breast Cancer: A Systematic Review and Meta-Analysis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biology
Volume 14
Issue 8
10.3390/biology14080991
biology-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Biology 2023, 12(2), 280.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Thu et al. Effect of Probiotics in Breast Cancer: A Systematic Review and Meta-Analysis. Biology 2023, 12, 280

by
May S. Thu
1,2,3,
Thunnicha Ondee
4,
Tanawin Nopsopon
4,5,6,
Izzati A. K. Farzana
4,
Joanne L. Fothergill
7,
Nattiya Hirankarn
1,
Barry J. Campbell
2,* and
Krit Pongpirul
4,5,8,9,*
1
Center of Excellence in Immunology and Immune-Mediated Diseases, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
2
Department of Infection Biology & Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L69 3GE, UK
3
Joint Chulalongkorn University—University of Liverpool PhD Programme in Biomedical Sciences and Biotechnology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
4
Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
5
School of Global Health, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
6
Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02215, USA
7
Department of Clinical Infection, Microbiology & Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L69 7BE, UK
8
Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21211, USA
9
Bumrungrad International Hospital, Bangkok 10110, Thailand
*
Authors to whom correspondence should be addressed.
Biology 2025, 14(8), 991; https://doi.org/10.3390/biology14080991
Submission received: 22 July 2025 / Accepted: 28 July 2025 / Published: 4 August 2025
(This article belongs to the Special Issue Pharmaceutical and Nutraceutical Manipulation of Gut Microbiota: Focus on Microbiome Characterization, Pharmacology, Diagnostics and Therapeutic Indications)
Browse Figure
Versions Notes

Text Correction

There was an error in the original publication [1]. Data was incorrectly extracted from Table 3 of Juan et al. [53], where we had taken the value for % body fat in the post-probiotic group and compared it to body weight in the post-placebo group. Data has been reanalyzed using the correct value for % body fat in the post-placebo group.
A correction has been made to Section 3.8.

3.8. Percentage Change in Body Fat

Three studies assessed percentage change in body fat (BF%) after probiotics intervention. Use of probiotics reduced BF% in both breast cancer patients and survivors (MD = −1.81; 95% CI: −5.22 to 1.61; p = 0.30; Figure 4A). Subgroup analysis demonstrated that ProLBE supplements significantly reduced the elevation of BF% in breast cancer patients (MD = −4.20; 95% CI: −7.59 to −0.81; p = 0.02) while a smaller decrease in BF% occurred in breast cancer survivors with use of ProLBS capsules (Figure 4B).
As such, a correction has also been made to Table 4 and Figure 4 to reflect the revised analysis.
The corrected Table 4 appears below:
Table 4. Quantitative subgroup analysis for all the included trials.
Table 4. Quantitative subgroup analysis for all the included trials.
Subgroup/Sensitivity AnalysisNumber of TrialsSMD (95% CI)p-ValueHeterogeneity (I2, p-Value)
BMI
Probiotics ± prebioticsProbiotics only20.00 (−0.76, 0.77)0.9973% (0.05)
Combined with FOS3−0.05 (−0.29, 0.20)0.720% (0.99)
Intake duration10 weeks3−0.06 (−0.30, 0.19)0.650% (1.00)
8 weeks20.14 (−0.30, 0.58)0.5319% (0.27)
3 weeks1−0.34 (−0.75, 0.07)0.11N/A
Body weight
Probiotics ± prebioticsProbiotics only20.10 (−1.08, 1.28)0.8788% (0.004)
Combined with FOS2−0.01 (−0.32, 0.30)0.930% (0.54)
Intake duration10 weeks10.08 (−0.34, 0.49)0.73N/A
8 weeks20.27 (−0.57, 1.10)0.5375% (0.04)
3 weeks1−0.47 (−0.88, −0.06)0.03N/A
BF%
Probiotics ± prebioticsProbiotics only1−0.51 (−0.93, −0.09)0.02N/A
Combined with FOS2−0.03 (−0.34, 0.28)0.850% (0.86)
Intake duration10 weeks1−0.00 (−0.42, 0.41)0.98N/A
8 weeks1−0.06 (−0.52, 0.40)0.80N/A
3 weeks1−4.50 (−5.28, −3.72)<0.00001N/A
Waist circumference
Probiotics ± prebioticsProbiotics only14.0 (−1.44, 9.44)0.15N/A
Combined with FOS2−1.10 (−4.52, 2.31)0.530% (0.84)
Intake duration10 weeks1−0.14 (−0.56, 0.28)0.360% (1.00)
8 weeks20.19 (−0.24, 0.63)0.3918% (0.27)
Abbreviations: BMI, body mass index; BF%, percentage change in body fat; FOS, fructo-oligosaccharides; N/A, not available.
The corrected Figure 4 appears below:
Biology 14 00991 g004
Figure 4. Meta-analysis for (A) percentage change in body fat (BF%) percent and (B) BF% by probiotic type.
Figure 4. Meta-analysis for (A) percentage change in body fat (BF%) percent and (B) BF% by probiotic type.
Biology 14 00991 g004
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Thu, M.S.; Ondee, T.; Nopsopon, T.; Farzana, I.A.K.; Fothergill, J.L.; Hirankarn, N.; Campbell, B.J.; Pongpirul, K. Effect of Probiotics in Breast Cancer: A Systematic Review and Meta-Analysis. Biology 2023, 12, 280. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Thu, M.S.; Ondee, T.; Nopsopon, T.; Farzana, I.A.K.; Fothergill, J.L.; Hirankarn, N.; Campbell, B.J.; Pongpirul, K. Correction: Thu et al. Effect of Probiotics in Breast Cancer: A Systematic Review and Meta-Analysis. Biology 2023, 12, 280. Biology 2025, 14, 991. https://doi.org/10.3390/biology14080991

AMA Style

Thu MS, Ondee T, Nopsopon T, Farzana IAK, Fothergill JL, Hirankarn N, Campbell BJ, Pongpirul K. Correction: Thu et al. Effect of Probiotics in Breast Cancer: A Systematic Review and Meta-Analysis. Biology 2023, 12, 280. Biology. 2025; 14(8):991. https://doi.org/10.3390/biology14080991

Chicago/Turabian Style

Thu, May S., Thunnicha Ondee, Tanawin Nopsopon, Izzati A. K. Farzana, Joanne L. Fothergill, Nattiya Hirankarn, Barry J. Campbell, and Krit Pongpirul. 2025. "Correction: Thu et al. Effect of Probiotics in Breast Cancer: A Systematic Review and Meta-Analysis. Biology 2023, 12, 280" Biology 14, no. 8: 991. https://doi.org/10.3390/biology14080991

APA Style

Thu, M. S., Ondee, T., Nopsopon, T., Farzana, I. A. K., Fothergill, J. L., Hirankarn, N., Campbell, B. J., & Pongpirul, K. (2025). Correction: Thu et al. Effect of Probiotics in Breast Cancer: A Systematic Review and Meta-Analysis. Biology 2023, 12, 280. Biology, 14(8), 991. https://doi.org/10.3390/biology14080991

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop